Patent ID: 11883525
Assignee: DOSE MEDICAL CORPORATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 3:
4. An implant comprising:
axitinib, and
a bioerodible polyester polymer blend, comprising an ester end group poly-D,L-lactide-co-glycolide (PLGA) with a 75:25 or 85:15 lactide to glycolide ratio and an inherent viscosity of greater than about 0.32 dl/g and an acid or ester end group PLGA with an inherent viscosity selected from between about 0.16 dl/g to about 1.0 dl/g,
wherein the axitinib is present in the implant in an amount selected from a range of between about 5 and about 80 percent (w/w).